2B77:XETRA:XETRA-iShares Ageing Population UCITS Acc (EUR)

ETF | Others |

Last Closing

USD 7.196

Change

-0.04 (-0.53)%

Market Cap

USD 0.50B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.02 (-0.04%)

USD 96.80B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.77 (-0.77%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.24 (-1.00%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.02 (+0.17%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.04 (-0.67%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

N/A

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.06 (-0.47%)

USD 23.43B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.19 (-0.35%)

USD 19.49B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.07 (+0.66%)

USD 12.83B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.28 (+0.24%)

USD 12.26B

ETFs Containing 2B77:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.42% 55% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.42% 56% F 51% F
Trailing 12 Months  
Capital Gain 9.76% 69% C- 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.76% 69% C- 66% D+
Trailing 5 Years  
Capital Gain 59.45% 55% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 59.45% 55% F 56% F
Average Annual (5 Year Horizon)  
Capital Gain 8.83% 58% F 58% F
Dividend Return 8.83% 57% F 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.84% 32% F 44% F
Risk Adjusted Return 55.79% 47% F 53% F
Market Capitalization 0.50B 72% C 54% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.